US FDA approves Elanco's skin disease treatment for dogs
The U.S. Food and Drug Administration has approved Elanco Animal Health's skin disease treatment for dogs, the health ...
Elanco's Dermatology Treatment Secures FDA Approval For Itchy Dogs, Analyst Highlights Label Warnings And Efficacy
On Thursday, the FDA approved Elanco Animal Health Incorporated’s (NYSE:ELAN) Zenrelia, a once-daily oral JAK inhibitor for ...
Medical News Today9d
Can rosacea cause itchy skin?
This can lead to burning and itching. Treating rosacea with topical or oral medications may relieve itchiness. People can also try home treatments to alleviate itching, such as moisturizing the ...
Ipsen’s Iqirvo® (elafibranor) approved in the European Union as first new treatment for primary biliary cholangitis in nearly a decade
European Commission grants conditional marketing authorization for Iqirvo® (elafibranor), first-in-class new treatment for ...
verywellhealth13d
17 Evidence-Based Home Remedies for Mosquito Bites
Besides itching, mosquito bites swell up and may cause embarrassment if you get bit on the face. Apply one or more of these ...
The Healthy on MSN5d
20 Reasons for Your Itchy Scalp (Besides Head Lice)
A little itch is nothing to be concerned about, but if you can't stop scratching your head, here are some causes of an itchy ...
Verywell Health on MSN10d
Drug Rash: Which Drugs Cause Skin Symptoms?
Drug rashes are a common side effect in people taking antiseizures, antibiotics, or anti-inflammatories. Find out specific ...
Dupixent® (dupilumab) Phase 3 Trial Confirms Significant Improvements in Itch and Hives for Patients with Chronic Spontaneous Urticaria (CSU)
Confirming the results of Study A, this second pivotal trial in biologic-naïve patients met primary and key secondary endpoints, showing treatment with Dupixent resulted in a nearly 50% reduction in ...
Sanofi, Regeneron Drug Dupixent Shows Successful Treatment Of Patients With Inflammatory Skin Disease
Regeneron and Sanofi's Dupixent achieves positive Phase 3 results for chronic spontaneous urticaria, meeting key endpoints.